Development of Sustained Release Matrix Tablets of Metformin Using Natural Gums as Release Retardants

Authors

  • Dushyant Singh Translam Institute of Pharmaceutical Education and Research Meerut, UP.
  • Vikas Sharma Translam Institute of Pharmaceutical Education and Research Meerut, UP.
  • Dr. Nasiruddin Ahmad Farooqui Translam Institute of Pharmaceutical Education and Research Meerut, UP.
  • Naeem Translam Institute of Pharmaceutical Education and Research Meerut, UP.

Abstract

For treatment of DM there are several available drugs treatment for glycemic regulation.  So that systematic management for glycemic index still cure completely still challenges for most of medical scientific fraternity.  Thus its now became pathological treatment of disease advancement in perspective. In response to this todays life diabetes mellitus II like metformin hydrochloride. However in case of disadvantages fever compliance gastrointestinal side effect due to bio-half-life required more dose for long term treatment. For advancement according to raise efficacy. The current work aims to develop metformin hydrochloride sustained release matrix tablets using natural gums as release retardants in order to improve therapeutic efficacy and patient compliance. Natural gums like gum acacia, xanthan gum, and guar gum will be studied as hydrophilic matrix-forming agents because to their low toxicity, affordability, biodegradability, and biocompatibility. Wet granulation or direct compression will be used to create sustained release matrix tablets using various natural gum concentrations.

 

 

 

Downloads

Download data is not yet available.

References

Bangalore, S.; Fakheri, R.; Toklu, B.; Messerli, F.H. Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: Systematic review and meta-analysis of randomized trials. BMJ 2016, 352, i438.

Kumar, B.; Gupta, S.K.; Srinivasan, B.; Nag, T.C.; Srivastava, S.; Saxena, R.; Jha, K.A. Hesperetin rescues retinal oxidative stress, neuroinflammation and apoptosis in diabetic rats. Microvasc. Res. 2013, 87, 65–74.

Emdin, C.A.; Rahimi, K.; Neal, B.; Callender, T.; Perkovic, V.; Patel, A. Blood pressure lowering in type 2 diabetes: A systematic review and meta-analysis. JAMA 2015, 313, 603–615.

Bordoloi, R.; Dutta, K.N. A review on herbs used in the treatment of diabetes mellitus. J. Pharm. Chem. Biol. Sci. 2014, 2, 86–92.

DosSantos, J.M.; Tewari, S.; Mendes, R.H. The role of oxidative stress in the development of diabetes mellitus and its complications.J. Diabetes Res. 2019, 2019, 4189813.

Al Moustafa, A.-E.; Al-Antary, N.; Yasmeen, A. High-Risk Human Papillomavirus and Colorectal Carcinogenesis. In Human Papillomavirus-Research in a Global Perspective; IntechOpen: London, UK, 2016.

Boots, A.W.; Haenen, G.R.; Bast, A. Health effects of quercetin: From antioxidant to nutraceutical. Eur. J. Pharmacol. 2008, 585, 325–337. [CrossRef] [PubMed]

Carlström, M.; Larsen, F.J.; Nyström, T.; Hezel, M.; Borniquel, S.; Weitzberg, E.; Lundberg, J.O. Dietary inorganic nitrate reverses features of metabolic syndrome in endothelial nitric oxide synthase-deficient mice. Proc. Natl. Acad. Sci. USA 2010, 107,

17716–17720.

Coniff, R.F.; Shapiro, J.A.; Seaton, T.B.; Bray, G.A. Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tol-butamide-plus-acarbose in non-insulin-dependent diabetes mellitus. Am. J. Med. 1995, 98, 443–451.

Drummond,R.S.; Lyall, M.; McKnight, J. Statins should be routinely prescribed in all adults with diabetes. Pract. Diabetes Int.2010, 27, 404–406.

Emer, J.J.; Claire, W. Rituximab: A review of dermatological applications. J. Clin. Aesthetic Dermatol. 2009, 2, 29–37.

Published

2026-06-15

How to Cite

Dushyant Singh, Vikas Sharma, Dr. Nasiruddin Ahmad Farooqui, & Naeem. (2026). Development of Sustained Release Matrix Tablets of Metformin Using Natural Gums as Release Retardants. Asian Journal of Pharmaceutical Research and Development, 14(3), 326–332. Retrieved from https://mail.ajprd.com/index.php/journal/article/view/1798

Issue

Vol. 14 No. 3 (2026): Volume 14 Issue 3 May - June 2026

Section

Research Articles

Copyright (c) 2026 Dushyant Singh, Vikas Sharma, Dr. Nasiruddin Ahmad Farooqui, Naeem

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).